Bioequivalence of pioglitazone tablet to Actos® tablet (Pioglitazone 30 mg) |
Yeom, Hyesun
(College of Pharmacy, Chung-Ang University)
Lee, Tae Ho (College of Pharmacy, Chung-Ang University) Youm, Jeong-Rok (College of Pharmacy, Chung-Ang University) Song, Jin-Ho (College of Medicine, Chung-Ang University) Han, Sang Beom (College of Pharmacy, Chung-Ang University) |
1 | Takeda Pharmaceutical Company Limited, Actos (pioglitazone hydrochloride) Full Prescribing Information, Osaka, Japan, 2004, http://www.actos.com/pi.pdf |
2 | FDA Guidelines, Bioequivalence Food and Drug Administration, Division of Bioequivalence, Office of Generic Drugs, Rockville, MD USA, 1992 |
3 | P. Sripalakit, P. Neamhom and A. Saraphanchotiwitthaya, J. Chromatogr. B, 843, 164-169(2006) DOI ScienceOn |
4 | 식품의약품안전청 고시 제 2007-65호, 생물학적동등성시험기준 (2007. 09. 20) |
5 | Y. J. Xue, K. C. Turner, J. B. Meeker, J. Pursley, M. Arnold and S. Unger, J. Chromatogr. B, 795, 215-226(2003) DOI ScienceOn |
6 | S. Wittayalertpanya, S. Chompootaweep and N. P. Thaworn, J. Med. Assoc. Thailand, 89, 2116-2122(2006) ScienceOn |
7 | J. Waugh, G. M. Keating, G. L. Plosker, S. Easthope and D. M. Robinson, Drugs, 66, 85-109(2006) DOI ScienceOn |
8 | J. Chilcott, MSc, P. Tappenden, M. L. Jones, M. A. DPhU and J. P. Wight, Clin. Therapeut., 23, 1792 (2001) PUBMED |
9 | J. Sakamoto, H. Kimura, S. Moriyama, H. Odaka, Y. Momose, Y. Sugiyama and H. Sawada, Biochem. Biophys. Res. Commun., 278, 704-711 (2000) DOI ScienceOn |
10 | J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson and S. A. Kliewer, J. Biol. Chem., 270, 12953-12956(1995) DOI ScienceOn |
11 | International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of analytical procedures, ICH-Q2A, Geneva, 1995 |